Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer.
Pharmaceutics
Leone, Gian Marco GM; Candido, Saverio S; Lavoro, Alessandro A; Vivarelli, Silvia S; Gattuso, Giuseppe G; Calina, Daniela D; Libra, Massimo M; Falzone, Luca L
The Genomics of Colorectal Cancer in Populations with African and European Ancestry.
Cancer Discovery
Myer, Parvathi A PA; Lee, Jessica K JK; Madison, Russell W RW; Pradhan, Kith K; Newberg, Justin Y JY; Isasi, Carmen R CR; Klempner, Samuel J SJ; Frampton, Garrett M GM; Ross, Jeffery S JS; Venstrom, Jeffrey M JM; Schrock, Alexa B AB; Das, Sudipto S; Augenlicht, Leonard L; Verma, Amit A; Greally, John M JM; Raj, Srilakshmi M SM; Goel, Sanjay S; Ali, Siraj M SM
Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
The Oncologist
Ali, Siraj M SM; Sanford, Eric M EM; Klempner, Samuel J SJ; Rubinson, Douglas A DA; Wang, Kai K; Palma, Norma A NA; Chmielecki, Juliann J; Yelensky, Roman R; Palmer, Gary A GA; Morosini, Deborah D; Lipson, Doron D; Catenacci, Daniel V DV; Braiteh, Fadi F; Erlich, Rachel R; Stephens, Philip J PJ; Ross, Jeffrey S JS; Ou, Sai-Hong Ignatius SH; Miller, Vincent A VA